OTCM
AGNMF
Market cap74mUSD
Jul 08, Last price
0.07USD
1D
-6.15%
1Q
-15.31%
IPO
17.21%
Name
Agronomics Ltd
Chart & Performance
P/E
—
P/S
—
EPS
—
Div Yield, %
—
Shrs. gr., 5y
61.40%
Rev. gr., 5y
-6.69%
Revenues
-12m
L+42.83%
Net income
-33m
L+198.00%
CFO
-1m
L-92.96%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Agronomics Limited functions as a dedicated investment firm, primarily allocating capital across various financial instruments, including funds, equities, and equity-linked products. Its portfolio spans both publicly traded and privately held companies. The firm exhibits a strong preference for pioneering sectors such as alternative proteins, with a specific focus on cellular agriculture, the rapidly expanding modern food industry, and the broad biopharmaceutical space. A key strategy involves building a comprehensive investment portfolio within biotechnology and biopharmaceutical companies. Additionally, Agronomics diversifies its investments by acquiring shares in collective investment schemes that offer biopharma exposure, as well as long-term equity anticipation securities linked to biopharma sector assets or indices. The company also invests in biopharma sector debt, ensuring such investments do not exceed 15% of its net asset value. Agronomics Limited was founded on May 3, 2011, and is headquartered in Ramsey, Isle of Man.
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||